🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The proposed study V72P9E1 is an Extension Study of V72P9. The objectives o...
Status
Completed
Location
Oxford Vaccine Group, Center for Clinical Vaccinology and Tropical Medicine, Churchill Hospital
Start Date
2010-02
Trial ID
NCT01026974
Treatments Being Tested
The primary objective of this study is to demonstrate the equivalence of rM...
Status
Completed
Location
Royal Children's Hospital
Start Date
2011-08
Trial ID
NCT01423084
Treatments Being Tested
One year antibody persistence after the fourth dose boost or two catch-up d...
Status
Completed
Location
amostatná ordinace praktického lékaře pro děti a dorost Jindřichův Hradec
Start Date
2010-06
Trial ID
NCT01139021
Treatments Being Tested
The purpose of this trial is to assess the safety of a Meningococcal Group ...
Status
Completed
Location
01, Novartis Investigational Site
Start Date
2014-12
Trial ID
NCT02305446
Treatments Being Tested
The purpose of the current study is to evaluate whether there is immune int...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-09
Trial ID
NCT03587207
Treatments Being Tested
The purpose/aim of this study is to assess 1) the long-term persistence (4 ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-11-17
Trial ID
NCT02446743
Treatments Being Tested
The proposed study is an Extension Study of V72P13 to Evaluate the Safety, ...
Status
Completed
Location
Altenburger
Start Date
2009-02
Trial ID
NCT00847145
Treatments Being Tested
To explore safety, Tolerability and immunogenicity of two formulations of a...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00433914
This is a Phase II, randomized, observer-blind, placebo-controlled, multi-s...
Status
Completed
Location
University of Alabama at Birmingham School of Medicine - Infectious Disease
Start Date
2020-12-29
Trial ID
NCT04350138
Treatments Being Tested
This extension study V72P12E1 will investigate the safety, tolerability and...
Status
Completed
Location
Multiple Locations
Start Date
2009-07
Trial ID
NCT00944034
Treatments Being Tested